176 related articles for article (PubMed ID: 23999140)
1. Synthesis and antiviral activity of a novel class of (5-oxazolyl)phenyl amines.
Zhong ZJ; Zhang DJ; Peng ZG; Li YH; Shan GZ; Zuo LM; Wu LT; Li SY; Gao RM; Li ZR
Eur J Med Chem; 2013 Nov; 69():32-43. PubMed ID: 23999140
[TBL] [Abstract][Full Text] [Related]
2. 2-Alkyloxazoles as potent and selective PI4KIIIβ inhibitors demonstrating inhibition of HCV replication.
Keaney EP; Connolly M; Dobler M; Karki R; Honda A; Sokup S; Karur S; Britt S; Patnaik A; Raman P; Hamann LG; Wiedmann B; LaMarche MJ
Bioorg Med Chem Lett; 2014 Aug; 24(16):3714-8. PubMed ID: 25065492
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and structure-activity relationships of pyrazolo[3,4-d]pyrimidines: a novel class of potent enterovirus inhibitors.
Chern JH; Shia KS; Hsu TA; Tai CL; Lee CC; Lee YC; Chang CS; Tseng SN; Shih SR
Bioorg Med Chem Lett; 2004 May; 14(10):2519-25. PubMed ID: 15109643
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and hepatitis C antiviral activity of 1-aminobenzyl-1H-indazole-3-carboxamide analogues.
Shi JJ; Ji FH; He PL; Yang YX; Tang W; Zuo JP; Li YC
ChemMedChem; 2013 May; 8(5):722-5. PubMed ID: 23512654
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory properties of 2-substituent-1H-benzimidazole-4-carboxamide derivatives against enteroviruses.
Xue F; Luo X; Ye C; Ye W; Wang Y
Bioorg Med Chem; 2011 Apr; 19(8):2641-9. PubMed ID: 21441033
[TBL] [Abstract][Full Text] [Related]
6. Identification and Structure-Activity Relationships of Diarylhydrazides as Novel Potent and Selective Human Enterovirus Inhibitors.
Han X; Sun N; Wu H; Guo D; Tien P; Dong C; Wu S; Zhou HB
J Med Chem; 2016 Mar; 59(5):2139-50. PubMed ID: 26885567
[TBL] [Abstract][Full Text] [Related]
7. Discovery of 2-iminobenzimidazoles as potent hepatitis C virus inhibitors with a novel mechanism of action.
Windisch MP; Jo S; Kim HY; Kim SH; Kim K; Kong S; Jeong H; Ahn S; No Z; Hwang JY
Eur J Med Chem; 2014 May; 78():35-42. PubMed ID: 24675178
[TBL] [Abstract][Full Text] [Related]
8. Total synthesis of a noricumazole A library and evaluation of HCV inhibition.
Barbier J; Wegner J; Benson S; Gentzsch J; Pietschmann T; Kirschning A
Chemistry; 2012 Jul; 18(29):9083-90. PubMed ID: 22696300
[TBL] [Abstract][Full Text] [Related]
9. Novel anilinocoumarin derivatives as agents against hepatitis C virus by the induction of IFN-mediated antiviral responses.
Peng HK; Chen WC; Lee JC; Yang SY; Tzeng CC; Lin YT; Yang SC
Org Biomol Chem; 2013 Mar; 11(11):1858-66. PubMed ID: 23377187
[TBL] [Abstract][Full Text] [Related]
10. 9-Arylpurines as a novel class of enterovirus inhibitors.
Aguado L; Thibaut HJ; Priego EM; Jimeno ML; Camarasa MJ; Neyts J; Pérez-Pérez MJ
J Med Chem; 2010 Jan; 53(1):316-24. PubMed ID: 19924996
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antiviral activity against Coxsackie virus B3 of some novel benzimidazole derivatives.
Cheng J; Xie J; Luo X
Bioorg Med Chem Lett; 2005 Jan; 15(2):267-9. PubMed ID: 15603937
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and anti-enterovirus activity of new analogues of MDL-860.
Dobrikov GM; Slavchev I; Nikolova I; Stoyanova A; Nikolova N; Mukova L; Nikolova R; Shivachev B; Galabov AS
Bioorg Med Chem Lett; 2017 Oct; 27(19):4540-4543. PubMed ID: 28870395
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, structure-activity relationship and in vitro biological evaluation of N-arylethyl isoquinoline derivatives as Coxsackievirus B3 inhibitors.
Wang YX; Li YH; Li YH; Gao RM; Wang HQ; Liu YX; Gao LM; Lu QN; Jiang JD; Song DQ
Bioorg Med Chem Lett; 2011 Oct; 21(19):5787-90. PubMed ID: 21880491
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and anti-HCV activity of thiourea compounds.
Kang IJ; Wang LW; Lee CC; Lee YC; Chao YS; Hsu TA; Chern JH
Bioorg Med Chem Lett; 2009 Apr; 19(7):1950-5. PubMed ID: 19251415
[TBL] [Abstract][Full Text] [Related]
15. Discovery of naphtho[1,2-d]oxazole derivatives as potential anti-HCV agents through inducing heme oxygenase-1 expression.
Tseng CH; Lin CK; Chen YL; Tseng CK; Lee JY; Lee JC
Eur J Med Chem; 2018 Jan; 143():970-982. PubMed ID: 29232587
[TBL] [Abstract][Full Text] [Related]
16. Design and efficient synthesis of novel arylthiourea derivatives as potent hepatitis C virus inhibitors.
Kang IJ; Wang LW; Hsu SJ; Lee CC; Lee YC; Wu YS; Yueh A; Wang JC; Hsu TA; Chao YS; Chern JH
Bioorg Med Chem Lett; 2009 Nov; 19(21):6063-8. PubMed ID: 19796940
[TBL] [Abstract][Full Text] [Related]
17. Discovery of N-(4'-(indol-2-yl)phenyl)sulfonamides as novel inhibitors of HCV replication.
Chen G; Ren H; Turpoff A; Arefolov A; Wilde R; Takasugi J; Khan A; Almstead N; Gu Z; Komatsu T; Freund C; Breslin J; Colacino J; Hedrick J; Weetall M; Karp GM
Bioorg Med Chem Lett; 2013 Jul; 23(13):3942-6. PubMed ID: 23683596
[TBL] [Abstract][Full Text] [Related]
18. Discovery and characterization of a novel 7-aminopyrazolo[1,5-a]pyrimidine analog as a potent hepatitis C virus inhibitor.
Hwang JY; Windisch MP; Jo S; Kim K; Kong S; Kim HC; Kim S; Kim H; Lee ME; Kim Y; Choi J; Park DS; Park E; Kwon J; Nam J; Ahn S; Cechetto J; Kim J; Liuzzi M; No Z; Lee J
Bioorg Med Chem Lett; 2012 Dec; 22(24):7297-301. PubMed ID: 23159569
[TBL] [Abstract][Full Text] [Related]
19. Tetrazole and triazole as bioisosteres of carboxylic acid: discovery of diketo tetrazoles and diketo triazoles as anti-HCV agents.
Song WH; Liu MM; Zhong DW; Zhu YL; Bosscher M; Zhou L; Ye DY; Yuan ZH
Bioorg Med Chem Lett; 2013 Aug; 23(16):4528-31. PubMed ID: 23856047
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of Matijing-Su derivatives as potent anti-HBV agents.
Qiu J; Xu B; Huang Z; Pan W; Cao P; Liu C; Hao X; Song B; Liang G
Bioorg Med Chem; 2011 Sep; 19(18):5352-60. PubMed ID: 21872478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
